Within IDH-wild type GBM tumours, single-cell studies detected CD16ȡ immature NK cells, while in IDH1-mutant GBM tumours and brain metastases, CD16+ cytotoxic NK cells were present, albeit only scarcely contributing to overall tumour-infiltrating immune cell populations [68]. This evidence concerns the gene IDH1 and glioblastoma.